0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Surgical Site Infection"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Surgical Site Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Surgical Site Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Wound Care Market - Focused Insights 2024-2029 - Product Thumbnail Image

Wound Care Market - Focused Insights 2024-2029

  • Report
  • October 2024
  • 149 Pages
  • Global
From
EUR$2,990USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$2,999USDGBP
From
EUR$2,999USDGBP
From
EUR$2,999USDGBP
Loading Indicator

The Surgical Site Infection (SSI) market is a subset of the larger wound care market. SSIs are infections that occur after surgery, and can be caused by bacteria, fungi, or viruses. Wound care products used to treat SSIs include antiseptics, antibiotics, and dressings. Antiseptics are used to reduce the number of bacteria on the skin before surgery, while antibiotics are used to treat infections after surgery. Dressings are used to protect the wound from further infection and to promote healing. The SSI market is driven by the increasing prevalence of chronic diseases, such as diabetes, and the rising number of surgeries being performed. Additionally, the growing demand for advanced wound care products is expected to drive the market. Some companies in the SSI market include Smith & Nephew, 3M, Mölnlycke Health Care, ConvaTec, and Coloplast. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more